Medication nonadherence: an unrecognized cardiovascular risk factor.
about
Noncompliance in the use of cardiovascular medications in the Medicare Part D populationTreatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitorsAssociation between adherence to calcium-channel blocker and statin medications and likelihood of cardiovascular events among US managed care enrollees.The RISAP-study: a complex intervention in risk communication and shared decision-making in general practiceEffect of self-efficacy and social support on adherence to antihypertensive drugs.Determinants for acceptance of preventive treatment against heart disease - a web-based population survey.Factors contributing to nonadherence to oral hypoglycemic medications among ambulatory type 2 diabetes patients in Southwestern Nigeria.Predictors of health-related quality of life in patients at risk for cardiovascular disease in European primary care.Attitudes and cardiovascular disease.Medication Adherence in Older Adults: A Qualitative Study.Adherence to cardiovascular disease medications: does patient-provider race/ethnicity and language concordance matter?Medication effectiveness may not be the major reason for accepting cardiovascular preventive medication: a population-based surveyPredictors of uncontrolled hypertension and antihypertensive medication nonadherencePharmacist intervention program to enhance hypertension control: a randomised controlled trialA new Web-based medical tool for assessment and prevention of comprehensive cardiovascular risk.Comprehension of complex instructions deteriorates with age and vascular morbidity.Medication Discussion Questions (MedDQ): developing a guide to facilitate patient-clinician communication about heart medications.Relationship between medication use and cardiovascular disease health outcomes in the Jackson Heart Study.Medication adherence among rural, low-income hypertensive adults: a randomized trial of a multimedia community-based interventionBaseline medication adherence and blood pressure in a 24-month longitudinal hypertension study.Feasibility of partnering with emergency medical services to identify people at risk for uncontrolled high blood pressure.Effect of Behavior Modification on Outcome in Early- to Moderate-Stage Chronic Kidney Disease: A Cluster-Randomized Trial.Poor blood pressure control and its associated factors among older people with hypertension: A cross-sectional study in six public primary care clinics in Malaysia.Optimizing terminology for stroke motor rehabilitation: recommendations from the American Congress of Rehabilitation Medicine Stroke Movement Interventions Subcommittee.Adherence to lipid-lowering treatment: the patient perspective.Medication-taking among adult renal transplant recipients: barriers and strategies.Evaluation and implementation of behavioral and educational tools that improves the patients' intentional and unintentional non-adherence to cardiovascular medications in family medicine clinics.Incomplete medication adherence of chronically ill patients in German primary care.Prevalence and correlates of self-reported medication non-adherence among older adults with coronary heart disease, diabetes mellitus, and/or hypertension.Confirming the theoretical structure of expert-developed text messages to improve adherence to anti-hypertensive medications.Sex differences in barriers to antihypertensive medication adherence: findings from the cohort study of medication adherence among older adults.Medication adherence, self-care behaviour and knowledge on heart failure in urban South Africa: the Heart of Soweto study.Nonadherence to antihypertensive medications and associated factors in general medicine clinicsDo diabetes-specialty clinics differ in management approach and outcome? A cross-sectional assessment of ambulatory type 2 diabetes patients in two teaching hospitals in Nigeria.Comparison of diet quality, physical activity and biochemical values of older adults either reporting or not reporting use of lipid-lowering medicationTreatment adherence and quality of life in patients on antihypertensive medications in a Middle Eastern population: adherence.The Association between Trust in Health Care Providers and Medication Adherence among Black Women with Hypertension.Ethical considerations in adherence research.Current practice and clinicians' perception of medication non-adherence in patients with inflammatory bowel disease: A survey of 98 clinicians.Medication adherence among ambulatory patients with type 2 diabetes in a tertiary healthcare setting in southwestern Nigeria.
P2860
Q33567812-177F4312-E2CE-44C3-A0BC-5D0B04BF4097Q33603379-2CFA9178-9327-4B5E-AF06-A332498034FEQ33610927-6C6488F9-F61B-4584-ACE2-9AACCEF86D5AQ33699363-309AAA6A-3B31-46AE-A815-8BBF600BBEF4Q33814102-5D9936F5-8398-4DD9-B5D5-AC89F73C0CBFQ34062586-BE5F028F-F38E-4D93-A568-CD6E57CCA61CQ34069718-4E739B40-1389-4C9E-BC8E-B4CB5D61A474Q34117492-0B86A069-E275-454B-B1C3-970B00D9841AQ34143055-AC561A2D-81E1-44E9-8B8C-EABAD1573D0EQ34149142-EB0AB371-5050-4196-974A-CD9FC7C61DE7Q34164232-FA0790CE-930A-4B68-8CFF-F9DDC8FA6E38Q34371333-2857AF6C-5C6D-4F57-AB9F-4AA464271BDEQ34504821-56AB55C8-5D0B-439A-A46C-A8404BD8315AQ34588148-95C0ACFE-6CD6-43DC-B801-A9B4A09CDCC4Q34703804-0ABADD86-729E-43F0-91E9-68F81274416AQ34714790-ADE24F94-48F8-4C92-B742-453AE4D4ACFAQ35042827-788DAC8C-2B91-4FF8-986C-C57F415C2FADQ35110175-64B38301-404C-4CD7-A55C-4791542A5393Q35620554-200589E9-AAE7-46F3-B31D-5064005A09E0Q35795083-748982D2-DBFE-41AB-B17F-0143458449C6Q35922666-0532473B-68F1-4694-8D4E-5FD815C27B76Q35964981-F4AE5370-56D3-4527-9E27-12E5521AA012Q36054207-4FF306AA-3374-408B-90DC-0B8A29966063Q36146079-EBAA5F87-ADB1-4B37-9BA8-6D375128DA82Q36394334-3DD146D7-921B-4AC4-90E1-667121AB294DQ36520121-49C0A32D-8BEA-4349-8DD3-0EA45A16F35BQ36689998-97FC54DB-3B9C-48D6-AB2B-E144981DDBB3Q36738486-A8332450-D7D9-4996-8740-7B7BD55AAB94Q36751595-B3443E86-A1D1-4849-AB33-E7669EA1619AQ36760184-FBB5ABB6-79B3-48FD-A7BA-BE5D6C4378F0Q36771897-38CF13DA-4D62-4062-A54E-CB81A6BCE163Q37041457-64FCCD13-246D-4B45-9A33-6224DF00B667Q37154992-CE49DACD-2378-4241-BE89-9DD51C7F6F69Q37233760-C82B60E1-5A1D-4E1A-9F35-49C3044AC052Q37320254-E482135D-ED81-49D9-91B3-DBFE6A3C9F3AQ37385309-CAACA4B5-97C5-4493-ABAD-B0FD5B449585Q37385446-BDF9303D-1F3B-4ACA-8EEB-14E503FD46CDQ37488819-1F6E0B49-A770-495F-BDB3-9084AFF572C9Q37625522-4D8621EC-E70D-4E21-97D1-C4CB5E78FA34Q37672513-B8DD11C7-2E48-4D89-812F-E5BD0DCADB34
P2860
Medication nonadherence: an unrecognized cardiovascular risk factor.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 September 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Medication nonadherence: an unrecognized cardiovascular risk factor.
@en
Medication nonadherence: an unrecognized cardiovascular risk factor.
@nl
type
label
Medication nonadherence: an unrecognized cardiovascular risk factor.
@en
Medication nonadherence: an unrecognized cardiovascular risk factor.
@nl
prefLabel
Medication nonadherence: an unrecognized cardiovascular risk factor.
@en
Medication nonadherence: an unrecognized cardiovascular risk factor.
@nl
P2093
P1476
Medication nonadherence: an unrecognized cardiovascular risk factor.
@en
P2093
Benjamin W Van Tassell
Joanne LaFleur
Mark A Munger
P577
2007-09-19T00:00:00Z